Vincenzo Di Marzo
Pozzuoli, 80078, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Endocannabinoids: an appetite for fat.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 23, 2011
Gut feelings about the endocannabinoid system.
Journal: Neurogastroenterology and motility
Published: April 13, 2011
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction.
Journal: Expert review of neurotherapeutics
Published: April 01, 2011
Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.
Journal: Nature neuroscience
Published: December 29, 2010
CB1 antagonists for obesity--what lessons have we learned from rimonabant?
Journal: Nature reviews. Endocrinology
Published: October 22, 2009
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.
Journal: European journal of endocrinology
Published: September 12, 2009
The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation.
Journal: International journal of obesity (2005)
Published: June 17, 2009
The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.
Journal: Pharmacological research
Published: January 28, 2009
CB(1) receptor antagonism: biological basis for metabolic effects.
Journal: Drug discovery today
Published: May 21, 2008
Endocannabinoids: synthesis and degradation.
Journal: Reviews of physiology, biochemistry and pharmacology
Published: May 16, 2008
Play an ADAGIO with a STRADIVARIUS: the right patient for CB1 receptor antagonists?
Journal: Nature clinical practice. Cardiovascular medicine
Published: May 13, 2008
Last Updated: 09/26/2026